TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14640996

Group type: EXPERIMENTAL
Intervention: Cushing's syndrome patients (ET-1 levels)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Adrenal adenoma patients
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Patients who died of severe cardiovascular complications
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cushing's syndrome patients (cholesterol correlation)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Successful treatment of hypercortisolism
Number of subjects: 13
Study: 11000585

Group type: EXPERIMENTAL
Intervention: Intracoronary balloon inflation during RCA angioplasty
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Recovery after balloon deflation
Number of subjects: 7
Study: 8814846

Group type: EXPERIMENTAL
Intervention: Step planimetry
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dimensional method
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dimensional method with anterior deflection of the probe
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dimensional method with posterior deflection of the probe
Number of subjects: 45

Group type: COMPARATOR
Intervention: Computer-enhanced images
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dimensional method using maximum dimensions from planimetric contours
Number of subjects: 45

Group type: COMPARATOR
Intervention: TRUS using the prolate ellipsoid formula
Number of subjects: 45
Study: 1505304

Group type: EXPERIMENTAL
Intervention: HUL/R (twice-daily humulin ultralente insulin)
Number of subjects: 31

Group type: COMPARATOR
Intervention: HL/R (control group)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HUL/R and HL/R
Number of subjects: 31
Study: 6388585

Group type: EXPERIMENTAL
Intervention: Combination of clotrimazole and hydrocortisone (Canesten HC)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Clotrimazole alone
Number of subjects: 192

Group type: COMPARATOR
Intervention: Hydrocortisone alone
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Combination of clotrimazole and hydrocortisone
Number of subjects: 192
Study: 30771607

Group type: EXPERIMENTAL
Intervention: Childbirth preparation course
Number of subjects: 133

Group type: COMPARATOR
Intervention: Standard care in antenatal clinics
Number of subjects: 133
Study: 29391277

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Physical Therapy
Number of subjects: 171

Group type: COMPARATOR
Intervention: Tai Chi and Physical Therapy
Number of subjects: 171
Study: 27828820

Group type: EXPERIMENTAL
Intervention: Large-pore lightweight composite mesh placed in the intraperitoneal/onlay fashion using a modified Sugarbaker technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nonmesh (control group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Large-pore lightweight composite mesh
Number of subjects: 52
Study: 25270008

Group type: EXPERIMENTAL
Intervention: Earplugs with NRR of 25 with training
Number of subjects: 150

Group type: COMPARATOR
Intervention: Earplugs with NRR of 25 without training
Number of subjects: 150

Group type: COMPARATOR
Intervention: Earplugs with NRR of 30 without training
Number of subjects: 150
Study: 22436121

Group type: EXPERIMENTAL
Intervention: Complex care continuum intervention involving collaboration between a nurse with geriatric expertise, hospital ward staff, and a multi-professional team with a case manager
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Implementation fidelity evaluation
Number of subjects: 18
Study: 20515284

Group type: EXPERIMENTAL
Intervention: Biomarker testing (e.g., troponin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic intervention (e.g., cardiac catheterization)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation modelling studies
Number of subjects: 0
Study: 18068058

Group type: EXPERIMENTAL
Intervention: Intrapleural analgesia with 20 mL of 0.5% bupivacaine every 6 hours for 4 days
Number of subjects: 125
Study: 15545509

Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 309
Study: 12011120

Group type: EXPERIMENTAL
Intervention: Azacitidine (Aza C) 75 mg/m(2)/d subcutaneously for 7 days every 28 days
Number of subjects: 191

Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Azacitidine (Aza C)
Number of subjects: 191
Study: 9803110

Group type: EXPERIMENTAL
Intervention: Dorzolamide (one drop immediately after surgery)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg SR orally immediately post-operatively)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (received neither intervention)
Number of subjects: 59
Study: 7814228

Group type: EXPERIMENTAL
Intervention: Counterrotational electric toothbrush
Number of subjects: 12

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both brushes (Counterrotational electric toothbrush and Manual toothbrush)
Number of subjects: 12
Study: 2916783

Group type: EXPERIMENTAL
Intervention: 30% N2O/70% O2
Number of subjects: 34

Group type: COMPARATOR
Intervention: 100% O2
Number of subjects: 34
Study: 791332

Group type: EXPERIMENTAL
Intervention: Oxprenolol alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phentolamine (sustained administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of oxprenolol and phentolamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Labetalol (400 mg daily)
Number of subjects: 0
Study: 31110380

Group type: EXPERIMENTAL
Intervention: Ultrasonic device
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bipolar diathermy
Number of subjects: 38
Study: 28921414

Group type: EXPERIMENTAL
Intervention: Multimedia diabetes education program and nutrition therapy (NT + MDE)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Nutrition therapy only (NT)
Number of subjects: 351
Study: 25695189

Group type: COMPARATOR
Intervention: Ropivacaine alone (R)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ropivacaine with 50 μg dexmedetomidine (RD50)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ropivacaine with 100 μg dexmedetomidine (RD100)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ropivacaine with 150 μg dexmedetomidine (RD150)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ropivacaine with dexmedetomidine (all doses)
Number of subjects: 24
Study: 24021222

Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 70

Group type: COMPARATOR
Intervention: No-instruction control condition
Number of subjects: 70
Study: 21947289

Group type: EXPERIMENTAL
Intervention: Blood pressure target <140/90 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure target <130/80 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased frequency of BP control to <140/90 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased frequency of BP control to <130/80 mm Hg
Number of subjects: 0
Study: 18321486

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg three times a day)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (incremental dose)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Combination of metformin and clomiphene citrate
Number of subjects: 115
Study: 17204136

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) plus general practitioner (GP) supportive care
Number of subjects: 300

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 300
Study: 15515443

Group type: EXPERIMENTAL
Intervention: Indoor gardening activities, once a week for 5 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 5-week intervention program
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group received a 20-minute visit
Number of subjects: 66
Study: 11587494

Group type: COMPARATOR
Intervention: Naratriptan 0 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Naratriptan 2.5 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Naratriptan 5 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Naratriptan 10 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Naratriptan 20 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sub-D-optimal design with Naratriptan 0 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sub-D-optimal design with Naratriptan 10 mg
Number of subjects: 150
Study: 9154396

Group type: EXPERIMENTAL
Intervention: Lamisil DermGel (terbinafine 1% emulsion gel) applied once daily for 7 days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo gel applied once daily for 7 days
Number of subjects: 61
Study: 7957547

Group type: EXPERIMENTAL
Intervention: Flumequine (400 mg, three times daily for 5 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Theophylline (single i.v. dose)
Number of subjects: 8
Study: 3819220

Group type: EXPERIMENTAL
Intervention: Grass-pollen immunotherapy (IT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 18
Study: 29652278

Group type: EXPERIMENTAL
Intervention: Glargine + human insulin infusion during perioperative period
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline + human insulin infusion during perioperative period
Number of subjects: 50
Study: 27436224

Group type: EXPERIMENTAL
Intervention: Catheter Ablation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Rate Control
Number of subjects: 52
Study: 24510656

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 2446

Group type: COMPARATOR
Intervention: Comparator (active comparator or placebo)
Number of subjects: 2446
Study: 22325089

Group type: EXPERIMENTAL
Intervention: Statin therapy for 8 months
Number of subjects: 119
Study: 20951370

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (30 mg intravenous)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PTSD + MDD
Number of subjects: 32

Group type: COMPARATOR
Intervention: PTSD - MDD
Number of subjects: 32

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 32
Study: 17430533

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of an introductory class and consecutive classes using a case discussion method.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NANDA, NIC, and NOC nursing diagnoses, interventions, and outcomes implementation.
Number of subjects: 0
Study: 15822086

Group type: EXPERIMENTAL
Intervention: Diet commercials
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Diet commercials (early)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Diet commercials (midway)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Neutral commercials
Number of subjects: 193
Study: 12410536

Group type: EXPERIMENTAL
Intervention: surgical arm (n = 97)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: induction chemotherapy arm (n = 86)
Number of subjects: 183

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: all patients (regardless of treatment group)
Number of subjects: 183
Study: 7617555

Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg x 3)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2501544

Group type: EXPERIMENTAL
Intervention: Chemotherapy for premenopausal patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endocrine therapy for postmenopausal patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endocrine therapy for receptor-positive patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy for receptor-negative patients
Number of subjects: 0
Study: 921254

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 376
Study: 31377709

Group type: EXPERIMENTAL
Intervention: Cognitive-only training
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Cognitive-motor training
Number of subjects: 750

Group type: COMPARATOR
Intervention: Control group (minimal-intervention)
Number of subjects: 750
Study: 28079572

Group type: EXPERIMENTAL
Intervention: COPE
Number of subjects: 22
Study: 27750131

Group type: EXPERIMENTAL
Intervention: Exercise training (4-week program of closed-chain resistive activities and abdominal exercises)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 72
Study: 23262931

Group type: EXPERIMENTAL
Intervention: Chemotherapy after downregulation (estradiol less than 50 pg/mL) by GnRH antagonist and agonist (arm II)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chemotherapy after downregulation with GnRH agonist (arm IV)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chemotherapy alone (arm I)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chemotherapy alone (arm III)
Number of subjects: 100
Study: 21878782

Group type: EXPERIMENTAL
Intervention: Telephone depression care management + treatment as usual (TAU)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 38
Study: 19842222

Group type: EXPERIMENTAL
Intervention: Normal liquid food (NLF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-calorie diet (HCD)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Normal liquid food (NLF) 2 hours before surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-calorie diet (HCD) 2 hours before surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Normal liquid food (NLF) 3 hours before surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-calorie diet (HCD) 5 hours before surgery
Number of subjects: 80
Study: 16895612

Group type: EXPERIMENTAL
Intervention: low-Dye taping
Number of subjects: 92

Group type: COMPARATOR
Intervention: sham ultrasound
Number of subjects: 92
Study: 14564526

Group type: EXPERIMENTAL
Intervention: 20-week programme of aerobic conditioning progressing to 75% of initial VO(2max)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: 20-week programme of aerobic conditioning
Number of subjects: 742
Study: 11387608

Group type: EXPERIMENTAL
Intervention: 4F power injection (Acist)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 4F manual technique
Number of subjects: 96
Study: 9612618

Group type: EXPERIMENTAL
Intervention: Adjuvant multimodal treatment including pre- and postoperative chemoradiation, intraoperative radiotherapy (IORT), adjuvant chemotherapy, and regional infusion therapy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ongoing prospective randomized studies (ESPAC-1 and an EORTC study).
Number of subjects: 0
Study: 8070499

Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup (7.5 mg/kg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Acetaminophen syrup (10 mg/kg)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Both ibuprofen and acetaminophen
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup
Number of subjects: 154
Study: 2732400

Group type: EXPERIMENTAL
Intervention: Experimental clinical model
Number of subjects: 173
Study: 30659710

Group type: EXPERIMENTAL
Intervention: Presence of WML in type 1 diabetes patients
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (baseline)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (peak hyperemia)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (venous occlusion)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (capillary recruitment)
Number of subjects: 50
Study: 28257277

Group type: EXPERIMENTAL
Intervention: In-school saccadic training (King-Devick Reading Acceleration Program Software), 18 sessions of 20 minutes over 5 weeks
Number of subjects: 327

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 327
Study: 26349877

Group type: EXPERIMENTAL
Intervention: PTA for AVF
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: PTA for AVG
Number of subjects: 600

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 600
Study: 24640441

Group type: EXPERIMENTAL
Intervention: Universal restorative system (Adper Single Bond 2 system and Filtek Z350)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement (Vitremer)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Low shrink restorative system (Filtek P90)
Number of subjects: 132
Study: 21816996

Group type: EXPERIMENTAL
Intervention: Dynamic splinting (60 minutes, three times per day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (nonsteroidal anti-inflammatory drugs, orthotics, and home exercise program without dynamic splinting)
Number of subjects: 50
Study: 19015851

Group type: EXPERIMENTAL
Intervention: Full-endoscopic anterior cervical discectomy (FACD)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional anterior cervical decompression and fusion (ACDF)
Number of subjects: 103
Study: 16390354

Group type: EXPERIMENTAL
Intervention: mequitazine 10 mg q.a.m.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: dexchlorpheniramine Repetab 6 mg b.i.d.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg q.a.m.
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 14504025

Group type: EXPERIMENTAL
Intervention: TREAT (Treatment Research Experiences and Attitudes Task) - a 50-item patient-administered measure of attitudes
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Patients attending 80% or more clinical sessions
Number of subjects: 152
Study: 10917410

Group type: EXPERIMENTAL
Intervention: Risperidone 0.5 mg once daily at night, increased to a maximum of 2 mg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9300510

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Psychological factors
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Beliefs about pain and evaluation of seriousness of condition
Number of subjects: 71
Study: 7832031

Group type: EXPERIMENTAL
Intervention: Teachers participated in the educational intervention program workshops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Teachers did not participate in the educational intervention program workshops
Number of subjects: 0
Study: 2451549

Group type: EXPERIMENTAL
Intervention: Conventional doses (1 mg/kg/day) of corticotherapy
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Low doses (0.25 mg/kg/day) of corticotherapy
Number of subjects: 383
Study: 29729189

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-Fat Diet (LF)
Number of subjects: 48
Study: 28585260

Group type: EXPERIMENTAL
Intervention: Optimel Antibacterial Manuka Eye Gel (98% Leptospermum species honey) plus conventional therapy, n = 37
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Optimel Manuka plus Lubricant Eye Drops (16% Leptospermum species honey) plus conventional therapy, n = 37
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional therapy, n = 40
Number of subjects: 114
Study: 26282937

Group type: EXPERIMENTAL
Intervention: Operative hysteroscopy
Number of subjects: 572

Group type: COMPARATOR
Intervention: Vacuum aspiration
Number of subjects: 572
Study: 24496202

Group type: EXPERIMENTAL
Intervention: PF‐170H
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FLX‐18GW
Number of subjects: 0
Study: 21062998

Group type: EXPERIMENTAL
Intervention: NEVO sirolimus-eluting coronary stent (NEVO SES)
Number of subjects: 394

Group type: COMPARATOR
Intervention: TAXUS Liberté paclitaxel-eluting coronary stent (TAXUS Liberté PES)
Number of subjects: 394
Study: 18165285

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 17174201

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 746

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Thrombosis-related events
Number of subjects: 746
Study: 12938052

Group type: EXPERIMENTAL
Intervention: IFN-alpha2b (low dose) 3 million IU, twice a week for 2 years
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: IFN-alpha2b (high dose) 10 million IU, twice a week for 2 years
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 10629263

Group type: EXPERIMENTAL
Intervention: Tissue-engineered skin graft
Number of subjects: 31

Group type: COMPARATOR
Intervention: Moist dressing changes
Number of subjects: 31
Study: 9183072

Group type: EXPERIMENTAL
Intervention: Chemical retention brackets (Transcend)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Mechanical retention brackets (Transcend 2000)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Concise bonding agent
Number of subjects: 49

Group type: COMPARATOR
Intervention: Transbond bonding agent
Number of subjects: 49
Study: 1279784

Group type: EXPERIMENTAL
Intervention: sorbitol (2%)-mannitol (1%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1.5% glycine
Number of subjects: 40
Study: 3306639

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 91
Study: 29929157

Group type: EXPERIMENTAL
Intervention: Attentional bias modification (ABM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 54
Study: 27628128

Group type: COMPARATOR
Intervention: Specific exercise training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Turning-based treadmill training
Number of subjects: 36
Study: 24043557

Group type: EXPERIMENTAL
Intervention: Community Engagement Process (CEP) used by the Children's Healthy Living (CHL) Program
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Community Engagement Process (CEP)
Number of subjects: 900
Study: 23595928

Group type: EXPERIMENTAL
Intervention: Dyad practice group (n=24)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Single practice group (n=25)
Number of subjects: 49